Real-world experience of children with growth hormone deficiency who switched from daily growth hormone to the Long-Acting Growth Hormone Somatrogon

Study identification

• EU PAS number:
  EUPAS1000000829
• Study ID:
  1000000829
• Official title and acronym:
  Real-world experience of children with growth hormone deficiency who switched from daily growth hormone to the Long-Acting Growth Hormone Somatrogon
• DARWIN EU® study:
  No
• Study countries:
  Czechia

  Israel
• Study description:
  No information provided.
• Study status:
  Planned

Study timelines

Date when funding contract was signed

Planned:29/09/2025

Actual:29/09/2025

Study start date

Planned:05/01/2026

Date of final study report

Planned:31/03/2026

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable